abstract |
The present invention provides for the prevention and / or treatment of a subject suffering from or suspected of having coronary atherosclerosis and its related diseases, or at risk of suffering from coronary atherosclerosis and its related diseases. To a method for preventing and / or treating coronary atherosclerosis and related diseases in a subject, comprising administering to the subject an effective amount of plasminogen. The present invention further relates to a drug, a pharmaceutical composition, a product or a kit containing plasminogen for preventing and / or treating coronary atherosclerosis and its related diseases. |